UNIGE document Scientific Article
previous document  unige:7603  next document
add to browser collection

Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders

Tarr, P. E.
Bleiber, Gabriela
Furrer, Hansjakob
Rotger, Margalida
Martinez, Raquel
Battegay, Manuel
show hidden authors show all authors [1 - 15]
Published in The Journal of Infectious Diseases. 2005, vol. 191, no. 9, p. 1419-1426
Abstract BACKGROUND: Single-nucleotide polymorphisms in genes involved in lipoprotein and adipocyte metabolism may explain why dyslipidemia and lipoatrophy occur in some but not all antiretroviral therapy (ART)-treated individuals. METHODS: We evaluated the contribution of APOC3 -482C-->T, -455T-->C, and 3238C-->G; epsilon 2 and epsilon 4 alleles of APOE; and TNF -238G-->A to dyslipidemia and lipoatrophy by longitudinally modeling >2600 lipid determinations and 2328 lipoatrophy assessments in 329 ART-treated patients during a median follow-up period of 3.4 years. RESULTS: In human immunodeficiency virus (HIV)-infected individuals, the effects of variant alleles of APOE on plasma cholesterol and triglyceride levels and of APOC3 on plasma triglyceride levels were comparable to those reported in the general population. However, when treated with ritonavir, individuals with unfavorable genotypes of APOC3 and [corrected] APOE were at risk of extreme hypertriglyceridemia. They had median plasma triglyceride levels of 7.33 mmol/L, compared with 3.08 mmol/L in the absence of ART. The net effect of the APOE*APOC3*ritonavir interaction was an increase in plasma triglyceride levels of 2.23 mmol/L. No association between TNF -238G-->A and lipoatrophy was observed. CONCLUSIONS: Variant alleles of APOE and APOC3 contribute to an unfavorable lipid profile in patients with HIV. Interactions between genotypes and ART can lead to severe hyperlipidemia. Genetic analysis may identify patients at high risk for severe ritonavir-associated hypertriglyceridemia.
Keywords AllelesAnti-HIV Agents/ adverse effectsApolipoprotein C-IIIApolipoproteins C/ geneticsApolipoproteins E/ geneticsCD4 Lymphocyte CountCohort StudiesFemaleGenetic VariationHIV Infections/blood/ drug therapy/geneticsHumansHypertriglyceridemia/chemically induced/geneticsMaleMiddle AgedMultivariate AnalysisPolymorphism, Single NucleotideRisk AssessmentSwitzerlandTumor Necrosis Factor-alpha/ genetics
PMID: 15809899
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
TARR, P. E. et al. Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders. In: The Journal of Infectious Diseases, 2005, vol. 191, n° 9, p. 1419-1426. doi: 10.1086/429295 https://archive-ouverte.unige.ch/unige:7603

352 hits

0 download


Deposited on : 2010-06-21

Export document
Format :
Citation style :